Endotronix, Inc., a digital health and medical technology company, will relocate and expand its headquarters to Naperville, IL to support the full U.S. commercial launch of its Cordella Heart Failure System and Pulmonary Artery Sensor. Currently located in Lisle, IL, Endotronix has been headquartered in Chicagoland since 2013.
Located in the HUB 1415 building at 1415 W. Diehl Rd. In Naperville, the new facility will span 80,000 square feet, significantly increasing Endotronix’s manufacturing and operating capacity and allowing for a 30% workforce expansion as well as future growth. The first phase of construction is scheduled for completion in early 2023. Endotonix was represented by Newmark.
“Naperville offers an ideal location to plant our roots, offering a skilled workforce, affordable quality of life for our employees, desirable proximity to Chicago and strong sense of community,” said Harry Rowland, CEO of Endotronix.